Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Melanoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Skin Neoplasms 1Melanoma, Cutaneous Malignant 1Lymphoma, T-Cell 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Keratosis, Actinic 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

fludarabine phosphate 23Peripheral Blood Stem Cell Transplantation 23Cyclophosphamide 20Whole-Body Irradiation 18Mycophenolic Acid 16Cyclosporine 15Etoposide 11Tacrolimus 10Busulfan 10Antilymphocyte Serum 10Methotrexate 9Melphalan 9Bortezomib 9Vorinostat 6Rituximab 6Filgrastim 6Doxorubicin 6Vincristine 5Therapeutics 5Prednisone 5Lenalidomide 5tanespimycin 4Sirolimus 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Everolimus 4Carboplatin 4pembrolizumab 3Transplantation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × Cholecalciferol × Dermatologic × Clear all
NCT01787409 2025-12-30

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Mayo Clinic

Phase NA Active not recruiting
565 enrolled
DermatologicLymphoidOther hematologic neoplasm

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡